APA (7th ed.) Citation

A, F., Z, A., M, B., A, D., E, R., CK, L., . . . T, M. (2024). The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness program. HemaSphere, 8(6), e90. https://doi.org/10.1002/hem3.90

Chicago Style (17th ed.) Citation

A, Fagnan, et al. "The ETO2 Transcriptional Cofactor Maintains Acute Leukemia by Driving a MYB/EP300-dependent Stemness Program." HemaSphere 8, no. 6 (2024): e90. https://doi.org/10.1002/hem3.90.

MLA (9th ed.) Citation

A, Fagnan, et al. "The ETO2 Transcriptional Cofactor Maintains Acute Leukemia by Driving a MYB/EP300-dependent Stemness Program." HemaSphere, vol. 8, no. 6, 2024, p. e90, https://doi.org/10.1002/hem3.90.